Lumenis Ltd. has announced the U.S. launch of the Lumenis Pulse 120H Holmium laser platform for a range of urologic applications.
Lumenis Ltd. has announced the U.S. launch of the Lumenis Pulse 120H Holmium laser platform for a range of urologic applications.
The Pulse 120H is designed to provide urologists with a single solution for enhanced vaporization, enucleation, flexible ureteroscopy, and percutaneous nephrolithotomy procedures.
The laser platform is accompanied by a range of new fibers and accessories, enabling improved clinical outcomes, reduced treatment time, and increased patient satisfaction, according to Lumenis. They include:
“We strongly believe that with this new set of tools we have the right answers for reducing procedure time, while enhancing procedures' safety and efficacy to address the needs of all the major stakeholders in the health care industry: patients, physicians, providers, and insurers," said Lumenis CEO Tzipi Ozer-Armon.
The Pulse 120H platform is on display at the Lumenis booth (#1235) at this week’s AUA annual meeting.
Interested in urology products? Check out these recent articles:
AUA Exhibit Hall Highlights: Orlando 2014
New Urology Products and Services May 2014
New Urology Products and Services April 2014
To get weekly news from the leading news source for urologists, subscribe to the Urology Times eNews.
Dr. Chan on prevention, diagnosis, and treatment of kidney stones in pediatric patients
July 26th 2024"Stones that recur in children happen about 40% to 50% of the time. That's why the American Urological Association guidelines recommend doing a complete metabolic evaluation in all children," says Katherine Chan, MD, MPH.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.